Skip to main content
. 2021 Feb 17;10(2):195. doi: 10.3390/antibiotics10020195

Table 2.

Clinical data concerning MRONJ-related therapy.

MRONJ-Related Therapy Months
Duration of therapy
-Zoledronate 34.29 ± 33.42
-Alendronate 79.42 ± 63.33
-Denosumab 15 ± 7.94
Suspension of drug
-Zoledronate 8.53 ± 20.21
-Alendronate 13.15 ± 19.58
-Denosumab 0.8 ± 1.1